No Data
No Data
Liansheng Chemical (301212.SZ): Ruisheng Pharmaceutical has been re-certified as a high-tech enterprise.
On January 8, Gelonghui announced that Liansheng Chemical (301212.SZ) reported that its holding subsidiary, Le Ping City Ruisheng Pharmaceutical Co., Ltd. (referred to as 'Ruisheng Pharmaceutical'), recently received the 'High-tech Enterprise Certificate' jointly issued by the Jiangxi Provincial Department of Science and Technology, Jiangxi Provincial Department of Finance, and the State Administration of Taxation Jiangxi Provincial Taxation Bureau. Ruisheng Pharmaceutical has passed the re-certification as a high-tech enterprise.
Liansheng Chemical: 2024 Third Quarter Report
Liansheng Chemical: 2024 Semi-Annual Report
Liansheng Chemical: 2024 Semi-Annual Report Summary
Liansheng Chemical (301212.SZ) announced its performance for the first half of the year, with a net income of 16.4413 million yuan, a decrease of 72.03%.
Liansheng Chemical (301212.SZ) released its semi-annual report for 2024, with revenue of 0.301 billion...
Liansheng Chemical (301212.SZ): The net income in the first half of the year was 16.4413 million yuan, a year-on-year decrease of 72.03%.
Geelong Hui, August 28th | Liansheng Chemical (301212.SZ) released its 2024 interim report, with a total operating income of 0.301 billion yuan during the reporting period, a year-on-year decrease of 24.86%; the net income attributable to the shareholders of the listed company was 16.4413 million yuan, a year-on-year decrease of 72.03%; the net income attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 14.4079 million yuan, a year-on-year decrease of 74.92%; and the basic earnings per share was 0.15 yuan.